IndraLab

Statements


USP24 inhibits ABCG2. 1 / 1
| 1

reach
"In summary, USP24-i targeting USP24 activates autophagy to promote the degradation of ABCG2 and PD-L1, leading to the inhibition of drug resistance acquired from lung cancer therapy."